Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Ablation of AFib likely to occur later, be less successful in women

Women who received catheter ablation in the FIRE AND ICE trial were 37 percent more likely than men to have a recurrence of atrial arrhythmia and 36 percent more likely to be rehospitalized for cardiovascular causes, according to an analysis published April 26 in Circulation: Arrhythmia and Electrophysiology.

Thumbnail

Experts: Inflammation key to atherosclerosis—but more drug testing needed

Therapies targeting cholesterol and inflammation have both shown the ability to reduce cardiovascular events among patients with atherosclerosis, but more evidence is needed before anti-inflammatory drugs gain widespread use similar to statins, according to a consensus statement published May 14 in the European Journal of Preventive Cardiology.

Transcatheter mitral chordal replacement system successful in 1st human patient

The first patient to be treated with a novel mitral valve repair system is recovering and showed no complications during a 30-day follow-up period, according to a press release issued by the system's developer.

Medtronic Begins U.S. Study of Drug-Eluting Stents to Evaluate Treatment of Bifurcation Lesions in Patients with Coronary Artery Disease

DUBLIN — May 16, 2018 — Medtronic plc (NYSE: MDT) today announced the initiation of a clinical study in the U.S. to assess the safety and efficacy of drug-eluting stents (DES) for the treatment of bifurcation lesions, which account for approximately 20 percent of all percutaneous coronary interventions (PCI).

The FH Foundation® Begins Enrollment in PAGENT Study to Improve Understanding of Genetic Testing for Familial Hypercholesterolemia (FH)

PASADENA, Calif., May 16, 2018 — The FH Foundation, a leading research and advocacy organization, today announced the launch of a new research study that aims to understand the willingness for individuals with a clinical diagnosis of familial hypercholesterolemia (FH) and their family members to undergo confirmatory genetic testing, through a partnership with Color Genomics.

Thumbnail

Pollution exposure as a fetus increases risk for elevated BP in childhood

Fetuses exposed to higher levels of air pollution during their mother’s third trimester of pregnancy have a higher risk of elevated blood pressure in childhood, according to a new study published online May 14 in the American Heart Association’s journal Hypertension.

Thumbnail

To PCI or not to PCI? Researchers develop predictive tool for stable CAD

Using data from the randomized COURAGE trial, a team of researchers developed a model to predict one-year angina and quality-of-life outcomes among patients with stable coronary artery disease (CAD).

Thumbnail

Genetic variant may contribute to alcoholic cardiomyopathy

Researchers have identified a genetic variant that may predispose individuals to alcoholic cardiomyopathy (ACM), possibly opening the door for genetic testing and familial evaluation.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.